Basit öğe kaydını göster

dc.contributor.authorÖzdemir, Vacide Aşık
dc.contributor.authorNural, Nesrin
dc.date.accessioned2024-05-07T05:57:58Z
dc.date.available2024-05-07T05:57:58Z
dc.date.issued2024en_US
dc.identifier.citationÖzdemir, V. A., & Nural, N. (2024). Risk Factors and Frequency of Foot Ulceration in Patients Receiving Chronic Hemodialysis Treatment. Advances in skin & wound care, 37(4), 203–210. https://doi.org/10.1097/ASW.0000000000000117en_US
dc.identifier.issn1527-7941
dc.identifier.urihttps://doi.org/10.1097/ASW.0000000000000117
dc.identifier.urihttps://hdl.handle.net/11436/8971
dc.description.abstractOBJECTIVE To determine the prevalence and risk factors of foot ulceration in patients receiving hemodialysis treatment. METHODS A total of 180 patients who received hemodialysis treatment in two state hospitals and a private health center between April 2017 and September 2017 were included in the study. The researchers collected data using a patient information form and by conducting physical evaluation of the lower extremities. They used the diabetic foot risk assessment algorithm to classify risk according to the data obtained. RESULTS Of the patients receiving hemodialysis treatment, 6.7% had foot ulceration, 19.4% had a history of foot ulceration, and 8.3% had a history of hospitalization associated with ulceration in a lower extremity. Infected foot ulceration was the most common (6.1%) cause of hospitalizations. In the group with current or past foot ulceration, diabetic nephropathy was the most common etiologic factor of end-stage kidney disease (48.6%); there was a significant between-group difference in diabetic nephropathy (P <.05). Etiologic factors had a significant effect on foot ulcerations: As determined by univariate logistic regression, diabetes (odds ratio [OR], 2.727; P <.05), presence of neuropathy (OR, 4.208; P <.05), low-density lipoprotein cholesterol (OR, 1.013; P <.05), and serum albumin (OR, 0.302; P <.036) all had a statistically significant effect on the presence of foot ulcerations. CONCLUSIONS Patients receiving hemodialysis treatment are at high risk for foot ulceration. Therefore, patient awareness strategies should be expanded to include individuals with end-stage renal disease regardless of diabetes status. Clinical and dialysis nurses should educate these patients about foot ulcerations and foot health to prevent ulcer development.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams and Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic kidney diseaseen_US
dc.subjectFoot ulcerationen_US
dc.subjectHemodialysisen_US
dc.subjectPrevalenceen_US
dc.subjectRisk factorsen_US
dc.subjectUlceren_US
dc.titleRisk factors and frequency of foot ulceration in patients receiving chronic hemodialysis treatmenten_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Sağlık Yüksekokulu, Hemşirelik Bölümüen_US
dc.contributor.institutionauthorÖzdemir, Vacide Aşık
dc.identifier.doi10.1097/ASW.0000000000000117en_US
dc.identifier.volume37en_US
dc.identifier.issue4en_US
dc.identifier.startpage203en_US
dc.identifier.endpage210en_US
dc.relation.journalAdvances in Skin and Wound Careen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster